Inito

Inito develops lab-grade, at-home diagnostic products and a companion software platform focused on hormone monitoring. Its flagship FDA-registered fertility monitor combines a small reader device, single-use test strips that measure four key fertility hormones (estrogen, LH, progesterone metabolite PdG, and FSH), and a mobile app that quantitatively interprets results using AI models. The company positions its offering for direct-to-consumer fertility tracking while building a broader platform to support additional at-home hormone and health tests, integrating hardware, biosciences R&D, and data-driven software insights.